E Fund Management Co., Ltd. Cytokinetics Inc Transaction History
E Fund Management Co., Ltd.
- $1.97 Billion
- Q4 2024
A detailed history of E Fund Management Co., Ltd. transactions in Cytokinetics Inc stock. As of the latest transaction made, E Fund Management Co., Ltd. holds 11,744 shares of CYTK stock, worth $510,041. This represents 0.03% of its overall portfolio holdings.
Number of Shares
11,744
Previous 13,737
14.51%
Holding current value
$510,041
Previous $725,000
23.86%
% of portfolio
0.03%
Previous 0.04%
Shares
15 transactions
Others Institutions Holding CYTK
# of Institutions
397Shares Held
122MCall Options Held
3.46MPut Options Held
1.86M-
Black Rock Inc. New York, NY14.7MShares$637 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.9MShares$518 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD10.8MShares$467 Million0.31% of portfolio
-
Wellington Management Group LLP Boston, MA7.89MShares$343 Million0.07% of portfolio
-
State Street Corp Boston, MA6.17MShares$268 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $4.09B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...